Veröffentlichung: 13. Juli 2020 Zuletzt aktualisiert: 29. August 2025

Pharmaceutical packaging in top form with TPEs


KRAIBURG TPE, a recognized global TPE manufacturer in superior TPE compounds, has packaged its THERMOLAST® M TPE compounds for pharmaceutical packaging applications.

Product shelf-life has always been the priority in the development of packaging materials. For pharmaceutical products, it is a vital feature to protect against biological contamination while maintaining the quality of the product until it reaches the consumer. Thus, the material used for pharmaceutical packaging has to meet requirements such as provide protection against light, heat, and moisture as well as ensure that there is no chemical reaction with the packaged drug.

Furthermore, the materials used in pharmaceutical packaging have to allow for design flexibility and not add extra weight to the packaging, for easy handling and storage.

The use of polymer materials such as thermoplastic elastomers (TPEs) has been an important milestone in the development of pharmaceutical packaging as they render the required properties, such as excellent barrier protection against UV light as well as feature high impact strength and durability.

Meeting these requirements, KRAIBURG TPE, a global TPE manufacturer of a wide range of thermoplastic elastomer products and custom solutions for multiple industries, offers its THERMOLAST® M TPE compounds. This is specially developed for the medical and pharmaceutical industry and assures the specifications required for pharmaceutical packaging. The series meets the medical grade plastics international standards set in the USP Class VI, ISO 10993-4 (haemolysis), ISO 10993-5 (cytotoxicity), ISO 10993-10 (intracutaneous irritations) and ISO 10993-11 (acute system toxicity).

 

Antimicrobial properties of THERMOLAST® M

Biological contaminants are a major cause of spoilage of pharmaceutical products. The advantage with THERMOLAST® M TPE compounds is that they can be sterilized using methods such as EtO gas, superheated steam (134°C), γ-gamma ray treatment (2 x 35 kGy), β-ray (electron beam) treatment (2 x 35 kGy). Thus, these compounds are suited for applications like seals and valves in bottles for pharmaceutical storage, as well as for closures, septum, caps, infusion caps and ampoules in pharmaceutical packaging. The compounds can also be used in applications related to the process of transfer and filling in pharmaceutical industries.

Material performance for cost

The THERMOLAST® M TPE is developed with optimum productivity and cost-effectiveness in mind. Aside from the materials’ ample range of application possibilities, other features are the cost-effective molding process and short cycle time advantage for injection and two-component injection molding and extrusion processing, which allow manufacturers to boost their productivity. As well, the THERMOLAST® M TPE show excellent adhesion to various polymers such as PP, PE, COC, ABS, PS, PC, PET and PA.

Optimum purity with the Medical Service Package

KRAIBURG TPE provides a Medical Service Package that is orientated to delivering the highest quality standards of its TPE compounds, which are free of intentionally added heavy metals, latex, PVC and phthalates.

As well, the production of the compounds is permanently assigned in a separate processing unit, with the constant manufacturing process recorded in US FDA Drug Master Files (DMF).

Furthermore, the medical service package guarantees a 24-month supply of the compounds, allowing for supply security and long-term use by pharmaceutical packaging processors.

KRAIBURG TPE auf einen Blick
 

  • HQ & Produktionsstätte: Waldkraiburg / Deutschland
  • Regionale HQ & Produktionsstätten: Kuala Lumpur / Malaysia, Atlanta / USA
  • Produkte: Thermoplastische Elastomer Compounds
  • Brands: THERMOLAST®, COPEC®, HIPEX®, and For Tec E®
  • Märkte: Europa, Amerika, Asien Pazifik
  • Mitarbeiter: 660

Presseinformationen herunterladen

In unserem Medienpaket finden Sie umfassende Informationen, Grafiken und Bilder zum Thema.

13.07.2020 Medienpaket Pharmaceutical packaging in top form with TPEs

Aktuelle Neuigkeiten

KRAIBURG TPE erhält unabhängige UL-Validierung
14.10.2026 KRAIBURG TPE erhält unabhängige UL-Validierung KRAIBURG TPE hat für Universal PCR TPE der zweiten Generation eine Environmental Claim Validation (ECV) von UL Solutions erhalten. Die Validierung bestätigt einen Post-Consumer-Recycled-Content-(PCR)-Anteil von 70 bis 80 Prozent – abhängig von der jeweiligen Materialvariante. weiterlesen
KRAIBURG TPE unterstützt Kunden entlang der gesamten Wertschöpfungskette
12.10.2026 KRAIBURG TPE unterstützt Kunden entlang der gesamten Wertschöpfungskette Wenn regulatorische Anforderungen steigen, Lieferketten komplexer werden und Entwicklungszeiten kürzer ausfallen, gewinnen starke Entwicklungspartner an Bedeutung. Auf der Fakuma 2026 zeigt KRAIBURG TPE, wie Werkstoffkompetenz, regulatorisches Know-how und langfristige Partnerschaften Kunden dabei unterstützen, diese Herausforderungen erfolgreich zu meistern. weiterlesen
KRAIBURG TPE nutzt GoGreen Plus
30.09.2026 KRAIBURG TPE nutzt GoGreen Plus Mit Wirkung vom 1. März 2026 hat sich KRAIBURG TPE dem „GoGreen Plus“-Service des weltweiten Logistikanbieters DHL angeschlossen. Damit setzt KRAIBURG TPE im Bereich Logistik auf Lösungen zur Reduktion transportbezogener Treibhausgasemissionen. weiterlesen
KRAIBURG TPE veröffentlicht ersten globalen Sustainability Report
26.08.2026 KRAIBURG TPE veröffentlicht ersten globalen Sustainability Report Der neue unternehmensweite Bericht, der sich an den europäischen Nachhaltigkeitsberichtsstandards (ESRS) orientiert, bietet detaillierte Einblicke in ESG-Leistungen, Klimaschutzverpflichtungen und Materialinnovationen an allen Standorten weltweit. weiterlesen